Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Cancer Res. 2009 Aug 25;69(17):7004–7012. doi: 10.1158/0008-5472.CAN-09-0451

Figure 3. Prevalence of in vivo mutant cell proliferation in TP and non-TP IBD treated subjects.

Figure 3

Panel A) The proportion of subjects with evidence of in vivo expansion of mutant cells in TP and non-TP treated subjects. (*) 0% of non-TP treated children had evidence of mutant cell expansions. Panel B) The proportion of subjects with evidence of in vivo mutant cell expansion compared to total thiopurine dose.